We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
The pharmaceutical and biotech industry continues to deal with ongoing challenges especially in respect of strengthening their research and development (R&D) productivity and innovation model.
A recent McKinsey analysis calculates the average economic return on R&D has dropped from 13-15 percent in the 1990s to between 4-9 percent in the past decade.1
In response to this, the pharmaceutical industry is looking beyond their walls to embrace more collaboration outside of their own organizations.
Suppliers are a critical piece of this collaboration. West’s Global R&D and Global Technical Customer Support organizations understand the criticality of primary packaging to the success of new drug products and also of a package and its fit to a delivery system. We are stepping up to assist our customers proactively in addressing these challenges.
Of course, primary packaging related issues are only one aspect leading to the success of a new drug product, but they are a very important piece, nonetheless.
This overview speaks to the direction of our new global packaging systems organization for R&D and Technical Customer Support. We are building an integrated global network to strengthen and leverage our global talents to deliver more effectively at a local level. In addition, we are transforming the organization with the insight we gain from industry to assure new products and processes help meet your challenges in an effective manner with focus on Innovation, Science and Service.
1Economic return on R&D investment for top 10 biologic players. McKinsey perspective on drug & device R&D 2012.
The recent Pharmapack meeting in Paris provided a great global overview of the latest in pharmaceutical packaging and delivery. This meeting involved not only the traditional tradeshow, but presentations from pharmaceutical and biotechnology companies as well as from companies offering packaging and delivery systems.
As regulations increase across the pharmaceutical industry, reliable scientific evidence is needed to support the decisions being made during the drug development process in order to achieve the safe delivery of medicines to patients.
At West, our focus is on supporting the biopharmaceutical industry in qualification and commercialization of containment and delivery systems for injectable medicines. <span></span>Selecting high-quality drug packaging that meets regulatory standards is essential to a drug manufacturer’s success. <span></span>West’s top priority is delivering high-quality packaging products that meet the exacting quality standards and product specifications customers require.
West today announced a multi-year investment as part of the Company’s evolving research and development strategy. To better support pharmaceutical customers around the world, West will add capabilities to all of its global Packaging Systems R&D facilities, and develop two new R&D Centers of Excellence—one in the Asia Pacific region and one in Europe—to leverage regional capabilities and expertise in parenteral drug packaging.
In 2012, West rolled out a new global branding initiative that included a new tagline: By Your Side for a Healthier World<sup>TM</sup>. What does that mean? Every day, injectable drugs and vaccines are administered to improve the health of millions of patients around the world. And every day, West works by the side of its health care partners to design and manufacture drug packaging and delivery systems that will bring those drugs and vaccines from concept to the patient more efficiently, reliably and safely. This has been West’s legacy since the Company was founded in 1923.
English
Chinese
